The IPO activity in the U.S. pharma/biotech sector has had a strong showing so far this year, with 32 listings till the end of May. Although the first half of June witnessed no IPO activity in the healthcare sector, the second half is going to be busy, and 5 companies are making their public debut in the week ahead.
from RTT - Biotech http://bit.ly/2wWoX6i
via IFTTT
No comments:
Post a Comment